E.K. Azimova
Research Subjects
E.K. Azimova has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Azizzhon D. Zikiryachodzhaev
P.A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiology Center, Ministry of Health of Russia
1 shared publication - Daria Valerievna Bagdasarova
National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Koroleva St. 4, 249036 Obninsk, Russia
1 shared publication - Erik K. Saribekyan
Russian Biotechnological University (ROSBIOTECH)
1 shared publication - Maria Yu. Vlasova
National Medical Research Radiology Centre
1 shared publication - Sh. Sh. Abdulloeva
Московский научно-исследовательский онкологический институт имени П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России
1 shared publication
Latest Publications
- 1 January 2024
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 13 (3)
Targeted lymphadenectomy with sentinel lymph node biopsy in patients with breast cancer cT1-3N1M0 after neoadjuvant polychemotherapy
Currently, in the treatment of breast cancer, there is a steady trend towards minimizing the aggressiveness of treatment and de-escalating surgical intervention, which pushes clinicians around the world to look for new dicisions. Targeted lymphadenectomy is a method of surgical intervention in areas of regional lymphatic drainage, which includes marking a clinically positive lymph node before neoadjuvant polychemotherapy with various materials (carbon tattoo, radioactive iodine, metal clamps, etc.) followed by its intraoperative removal in combination with sentinel lymph node biopsy. Undoubtedly, targeted lymphadenectomy is an innovative and effective technique designed to be the answer to the question of the optimal volume of lymphadenectomy. This review is devoted to studying the main provisions of new approaches to surgical treatment of regional areas of breast cancer, namely de-escalation of the scope of surgical treatment in areas of regional lymphatic drainage through targeted lymphadenectomy.
- 1 January 2024
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 13 (3)
Targeted lymphadenectomy with sentinel lymph node biopsy in patients with breast cancer cT1-3N1M0 after neoadjuvant polychemotherapy
Currently, in the treatment of breast cancer, there is a steady trend towards minimizing the aggressiveness of treatment and de-escalating surgical intervention, which pushes clinicians around the world to look for new dicisions. Targeted lymphadenectomy is a method of surgical intervention in areas of regional lymphatic drainage, which includes marking a clinically positive lymph node before neoadjuvant polychemotherapy with various materials (carbon tattoo, radioactive iodine, metal clamps, etc.) followed by its intraoperative removal in combination with sentinel lymph node biopsy. Undoubtedly, targeted lymphadenectomy is an innovative and effective technique designed to be the answer to the question of the optimal volume of lymphadenectomy. This review is devoted to studying the main provisions of new approaches to surgical treatment of regional areas of breast cancer, namely de-escalation of the scope of surgical treatment in areas of regional lymphatic drainage through targeted lymphadenectomy.